BLBRF yields 3.39% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, BLBRF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BLBRF + JNJ for your $10,000?
Bloomberry Resorts Corporation, through its subsidiaries, develops, owns, and operates hotels, casinos, and integrated resorts in the Philippines and Korea. The company develops tourist facilities, such as casino-entertainment complexes with casino, hotel, retail and amusement areas, and themed development components. It also owns and operates the Solaire Resort & Casino, a hotel and gaming resort consists of slot machines, gaming tables, electronic table games, and specialty restaurants; hotel rooms, suites, and bayside villas; food and beverage outlets, including Chinese, Korean, and Japanese, and Italian restaurants, as well as international buffet/coffee shop, noodle shop, live entertainment lounge, food court, lobby bar, and lounge area; and multilevel parking building with parking slots, a spa and fitness center, and Bayview promenade. In addition, the company owns and operates the Sky Tower that consists of all-suite hotel; VIP gaming salons with gaming tables and slot machines; the bar for VIP patrons; meeting rooms with meeting facility, and boardrooms and pre-function area; a lyrical theater; the Waterside Restobar and Oasis Garden Café restaurants; shooting club with rifle shooting bays and pistol bays; and multi-level parking garage. Further, it operates Jeju Sun Hotel & Casino, including rooms, and gaming operation with tables and electronic gaming machines, as well as food and beverage outlets; and cruise terminals. The company is based in Paranaque City, the Philippines. Bloomberry Resorts Corporation is a subsidiary of Prime Strategic Holdings, Inc.
Full BLBRF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.